Maternal infection, a complex and multifaceted facet of maternal health, underscores the intricate interplay between infectious agents and pregnancy. The gravid state alters the immune response, rendering pregnant individuals both more susceptible to certain infections and potentially more vulnerable to severe complications. Maternal infections can arise from a variety of sources, including bacteria, viruses, parasites, and fungi, each presenting unique challenges in the context of pregnancy. Understanding the impact of maternal infections is paramount, as they can influence not only the health of the pregnant person but also have far-reaching consequences for fetal development and neonatal outcomes. Infections such as urinary tract infections (UTIs), bacterial vaginosis, and sexually transmitted infections (STIs) are common concerns during pregnancy. Left untreated, these infections may contribute to adverse outcomes, including preterm birth, low birth weight, or neonatal infections. The management of maternal infections requires a delicate balance, as certain antimicrobial agents may pose risks to the developing fetus. Thus, the careful consideration of the potential benefits and risks guides healthcare providers in determining the most appropriate course of treatment.
Viral infections, such as cytomegalovirus (CMV), herpes simplex virus (HSV), and human immunodeficiency virus (HIV), present unique challenges in the realm of maternal-fetal medicine. Maternal infections with these viruses may have profound implications for fetal development, ranging from congenital anomalies to neurodevelopmental disorders. The prevention, early detection, and management of maternal viral infections are critical components of prenatal care, necessitating a multidisciplinary approach involving obstetricians, infectious disease specialists, and neonatologists. Prevention is a key tenet in addressing maternal infections, and preconception care plays a vital role in identifying and managing potential infectious risks before pregnancy. Strategies such as vaccination, safer sexual practices, and lifestyle modifications contribute to reducing the likelihood of maternal infections and their associated complications. The symposium will also address the broader societal impact of maternal infections, emphasizing the importance of public health initiatives and education to empower individuals and communities in the prevention of infectious diseases during pregnancy.
Title : Male factors in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : Understanding pelvic organ prolapse
Woojin Chong, NYU Langone Medical Center, United States
Title : Efficacy of full piers calculator in predicting adverse maternal outcomes in preeclampsia at a tertiary care hospital in South India
Sangeetha Shah, Osmania Medical College, India
Title : Pulmonary embolism in pregnancy
Orfanoudaki Irene, University Hospital of Heraklion, Greece
Title : Role of artificial intelligence in the diagnosis and management of endometriosis. The prospect of the future
Mohamed Hosni, London North West University Hospitals, United Kingdom
Title : Vaginal colonization by uropathogenic microorganisms: A key contributor to reproductive failure in mice
Vijay Prabha, Panjab University, India